TIS 0.00% 0.0¢ tissue therapies limited

Ann: Investor Update, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 707 Posts.
    lightbulb Created with Sketch. 43
    Here it is: - from the AGM

    10. Approval of issue of options to Directors in lieu of fees and for Dr Christian Behrenbruch for executive performance
    To consider and, if thought fit, to pass the following resolutions as ordinary resolutions:
    ‘That, pursuant to section 208(1)(a) of the Corporations Act and Listing Rule 10.14, and in accordance with the Company’s Equity Option Plan, the members of the Company approve the granting of the following options:
    (a) 300,000 options to Dr Cherrell Hirst, non-Executive Director and Interim Chairman in lieu of directors fees,
    (b) 300,000 options to Mr Tim Hughes, non-Executive Director in lieu of directors fees, and
    (c) 1,000,000 options to Dr Christian Behrenbruch, Executive Director in lieu of directors fees and executive performance, in the manner outlined in the Explanatory Memorandum.’
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.